Products for Research Use Only
RegisterLogin

CR-1-31-B

CAT: 0804-HY-136453-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-136453-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B perturbs association of Plasmodium falciparum eIF4A (PfeIF4A) with RNA. CR-1-31-B induces apoptosis of neuroblastoma and gallbladder cancer cells[1][2][3][4].
CAS Number
1352914-52-3
UNSPSC
12352005
Target
Apoptosis; Eukaryotic Initiation Factor (eIF)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cr-1-31-b.html
Purity
98.38
Solubility
DMSO : 230 mg/mL (ultrasonic)
Smiles
O=C([C@H]([C@H]1C2=CC=CC=C2)[C@@H](O)[C@]3(O)[C@@]1(C4=CC=C(OC)C=C4)OC5=CC(OC)=CC(OC)=C35)NOC
Molecular Formula
C28H29NO8
Molecular Weight
507.53
References & Citations
[1]Jin C, Rajabi H, Rodrigo CM, Porco JA Jr, Kufe D. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Oncogene. 2013;32 (17) :2179-2188.|[2]Cao Y, et al. Targeting eIF4A using rocaglate CR 1 31B sensitizes gallbladder cancer cells to TRAIL mediated apoptosis through the translational downregulation of c FLIP. Oncol Rep. 2021;45 (1) :230-238. |[3]Langlais D, et al. Rocaglates as dual-targeting agents for experimental cerebral malaria. Proc Natl Acad Sci U S A. 2018;115 (10) :E2366-E2375. |[4]Skofler C, et al. Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma. Cells. 2021;10 (2) :301. Published 2021 Feb 2. |[5]Chan K, et al. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Nat Commun. 2019;10 (1) :5151. Published 2019 Nov 13.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF4

Related Products

CatalogName
HY-136453A-01CR-1-30-B
HY-161328MAO-B-IN-31
HY-P3609-01CR 665
HY-P11173Cr-ACP1
HY-P991054CR-8020
HY-16151CR-3294
HY-105298CR 3834
HY-N12760Lobophorin CR-2
HY-W998694-016-CR, 6G
HY-111011CR 665 (acetate)

Alternative Products

CatalogName
BA2780-5CR-1-31-B
5-01006Cripto-1, CR-1
T209379-01MAO-B-IN-31
sc-100564NDUFB3 (31-B)
GTR19150497-01Cbl-b-IN-31
ABC-TC0932RAW 309 Cr.1
sc-58515CRMP-5 (CR-1)
abx266743-01Cripto-1, CR-1 Peptide
T73522-01CR 665
MBS5780711CR 39

Popular Products